Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
“Toxic bile acid levels” is not a molecule or molecular target, but rather a pathological state arising when bile acids—which are amphipathic steroids produced by the liver to aid in fat digestion and cholesterol excretion—accumulate to abnormally high, cytotoxic concentrations in tissues or plasma. Bile acids are essential for normal digestion, but when their hepatic, biliary, or intestinal regulation fails (such as in cholestasis, ileal disease, or genetic bile acid synthesis disorders), their accumulation can damage hepatocytes, inflame the gastrointestinal tract, cause malabsorption, and contribute to disease progression in chronic liver conditions. Although drugs (e.g., bile acid sequestrants, ursodeoxycholic acid) aim to mitigate the toxic effects of excessive bile acids, “toxic bile acid levels” itself does not refer to a discrete target but rather a measurable disease process or biomarker. Caveat: “Toxic bile acid levels” is not a canonical molecular target (such as a receptor or enzyme), but a clinical/biochemical phenomenon, so this entry is better classified as a disease biomarker or pathophysiological state rather than a discrete drug target molecule.
Bile acid sequestrants (bind/neutralize bile acids in the gut to prevent toxic effects and diarrhea) Replacement of toxic with less toxic bile acids (e.g., ursodeoxycholic acid displaces more toxic bile acids)
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Toxic bile acid levels.